United-Guardian (NASDAQ:UG) Posts Earnings Results

United-Guardian (NASDAQ:UG) posted its quarterly earnings results on Monday. The company reported $0.20 earnings per share for the quarter, FiscalAI reports. United-Guardian had a net margin of 22.01% and a return on equity of 22.24%. The company had revenue of $3.49 million for the quarter.

United-Guardian Price Performance

Shares of NASDAQ:UG opened at $6.71 on Monday. The stock has a market cap of $30.83 million, a price-to-earnings ratio of 12.43 and a beta of 0.99. United-Guardian has a 12-month low of $5.58 and a 12-month high of $8.45. The business’s 50 day moving average is $7.02 and its 200 day moving average is $6.96.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “hold (c)” rating on shares of United-Guardian in a research report on Monday, October 19th. One research analyst has rated the stock with a Hold rating. Based on data from MarketBeat, United-Guardian currently has an average rating of “Hold”.

Hedge Funds Weigh In On United-Guardian

Several hedge funds have recently modified their holdings of UG. United Capital Financial Advisors LLC bought a new position in shares of United-Guardian during the 2nd quarter worth $143,000. BlackRock Inc. bought a new stake in United-Guardian in the 2nd quarter valued at about $105,000. Finally, Gamco Investors INC. ET AL raised its stake in United-Guardian by 1.2% in the 1st quarter. Gamco Investors INC. ET AL now owns 164,388 shares of the company’s stock valued at $1,101,000 after acquiring an additional 1,888 shares during the period. Institutional investors own 23.16% of the company’s stock.

About United-Guardian

United-Guardian, Inc is a specialty chemicals company that develops, manufactures and markets products for the personal care, pharmaceutical and industrial markets. The company serves customers in the United States and international markets through direct sales, distributors and commercial partners.

Its personal care portfolio includes Lubrajel, a family of water-based moisturizing and lubricating gels used in skin-care, hair-care, cosmetic and personal lubricant formulations. United-Guardian also supplies specialty ingredients designed to improve the texture, moisture retention and performance of finished consumer products.

In the pharmaceutical sector, the company markets Renacidin, a solution used under medical supervision for certain urinary tract applications, including the prevention and dissolution of specific types of urinary encrustations and stones.